Approval · Notice of Compliance 28008 · 2022

VRAYLAR: Notice of Compliance 28008

Issued April 22, 2022

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 28008
Date: April 22, 2022
Company: Allergan IncMarkham, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: New Active Substance (NAS)

Products in this notice

Brand	DIN	Status today
VRAYLAR	02526794	Marketed
VRAYLAR	02526808	Marketed
VRAYLAR	02526816	Marketed
VRAYLAR	02526824	Marketed

Medicinal ingredients

CARIPRAZINE HYDROCHLORIDE 1.5 MG per CAP
CARIPRAZINE HYDROCHLORIDE 3 MG per CAP
CARIPRAZINE HYDROCHLORIDE 4.5 MG per CAP
CARIPRAZINE HYDROCHLORIDE 6 MG per CAP